#3-81E. Decoding the Genetics of Sjögren’s Disease (Curr Opin Immunol, 2026)

How do genetic backgrounds influence the diverse manifestations and onset of Sjögren's disease (SjD)? This episode explores "The power of genetics in decoding Sjögren’s disease," a comprehensive review outlining the current landscape of SjD genetic risk loci identified through genome-wide association studies (GWAS) and their underlying pathomechanisms. The study's most crucial clinical takeaway highlights how specific genetic variants, such as TYK2, are emerging as novel therapeutic targets and revealing distinct genetic architectures between clinical subphenotypes, like anti-Ro/SSA antibody positive and negative patients. This discovery is a significant leap toward personalized medicine. However, when critically appraising this research, we must note that historical genetic data heavily skew toward European ancestries and the Ro/SSA+ subphenotype, which may limit the generalizability of these findings across diverse populations. For clinicians, these insights are invaluable; understanding the genetic drivers and the shift towards subphenotype-specific therapies will profoundly enhance how we classify disease pathology and tailor future treatment strategies in our daily practice.

Citation: Radziszewski M, Lessard CJ. The power of genetics in decoding Sjögren’s disease: current status and future development. Current Opinion in Immunology. 2026. DOI: 10.1016/j.coi.2025.102690

Disclaimer: This audio summary is based on personal interpretation and does not guarantee the exact content of the original paper. Please refer to the original article for details.